Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2018

Mar 9, 2018

32337_dirs_2018-03-09_cc21d417-d682-4ad8-8912-b1761947070a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-03-09

Reporting Person: LEVY ROBERT (EVP, The Americas)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-09 Common Stock M 33146 $6.82 Acquired 221457 Direct
2018-03-09 Common Stock D 2272 $99.53 Disposed 219185 Direct
2018-03-09 Common Stock F 16163 $99.53 Disposed 203022 Direct
2018-03-09 Common Stock M 100000 $6.82 Acquired 303022 Direct
2018-03-09 Common Stock D 6853 $99.53 Disposed 296169 Direct
2018-03-09 Common Stock F 48763 $99.53 Disposed 247406 Direct
2018-03-09 Common Stock M 24788 $6.82 Acquired 272194 Direct
2018-03-09 Common Stock D 5714 $99.53 Disposed 266480 Direct
2018-03-09 Common Stock F 9986 $99.53 Disposed 256494 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-09 Stock Appreciation Rights $6.82 M 33146 Disposed 2019-02-27 Common Stock (33146) Direct
2018-03-09 Stock Appreciation Rights $6.82 M 100000 Disposed 2019-02-27 Common Stock (100000) Direct
2018-03-09 Stock Appreciation Rights $22.94 M 24788 Disposed 2020-05-07 Common Stock (24788) Direct

Footnotes

F1: The reporting person received 14,711 shares of common stock upon the net exercise of 33,146 stock appreciation rights ("SARs"). The reporting person forfeited 2,272 shares of common stock underlying such SARS in payment of the exercise price and 16,163 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 9, 2018 of $99.53.

F2: The reporting person received 44,384 shares of common stock upon the net exercise of 100,000 SARs. The reporting person forfeited 6,853 shares of common stock underlying such SARS in payment of the exercise price and 48,763 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 9, 2018 of $99.53.

F3: The reporting person received 9,088 shares of common stock upon the net exercise of 24,788 SARs. The reporting person forfeited 5,714 shares of common stock underlying such SARS in payment of the exercise price and 9,986 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 9, 2018 of $99.53.